Aiforia Gets €20M EIB Financing for AI Cancer Diagnostics
Aiforia announced €20M in EIB financing. Here is what was disclosed, what the financing label means, and what investors should verify next.
healthcare — Venture Capital Articles & Research
Explore our latest articles on healthcare — covering venture capital deals, fund activity, startup fundraising strategy, and investor research relevant to this topic.
Whether you're a founder building an investor target list, an analyst tracking deal flow, or an operator researching market trends, the articles below provide practical, up-to-date venture capital intelligence.
Why This Topic Matters in VC
- Deal flow signal: Funding activity and investor conviction in healthcare
- Fundraising context: Which investors are active and what traction they expect
- Market timing: Sector momentum, valuation benchmarks, and competitive dynamics
Browse all healthcare articles below, or use our VC directory to research active investors by stage and sector.
Related Articles (18 articles)
-
-
LifeMine's $188M Series E: Fungal Biology Meets Transplant Drugs
LifeMine raised an oversubscribed $188M Series E (plus a prior $75M Series D) to push LIFE-001 — a novel calcineurin-pathway immunosuppressant — toward Phase 2 kidney transplant studies, with ARCH among continuing backers.
-
Expedition Therapeutics’ $115M Series B: General Atlantic Bets on COPD DPP1
General Atlantic led Expedition’s oversubscribed $115M Series B as the biotech dosed the first patient in a global Phase 2 COPD trial of EXPD-101 — a China-sourced NewCo twist.
-
Bain Capital Ventures Leads Hera $27M Series A for Senior Care AI
Bain Capital Ventures led Hera’s $27M Series A to expand its AI-powered senior care coordination platform, with Accel and IA Ventures participating.
-
AlleyCorp Leads Vanna Health Round for Serious Mental Illness Care
AlleyCorp led a round for Vanna Health, which delivers evidence-based care for people living with serious mental illness, extending the firm’s healthcare vertical.
-
Canaan Partners Leads Vedana Therapeutics Series A
Canaan Partners led a Series A for Vedana Therapeutics, extending the firm’s healthcare franchise as it deploys its $850M Fund XIII.